Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  EnteroMedics Inc    ETRM

 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 0,70 M
EBIT 2016 -30,2 M
Net income 2016 -30,5 M
Debt 2016 -
Yield 2016 -
Sales 2017 2,30 M
EBIT 2017 -32,8 M
Net income 2017 -28,5 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 2,79x
Capi. / Sales2017 0,85x
Capitalization 1,95 M
More Financials
Company
EnteroMedics, Inc. is a clinical development stage medical device company that engages in the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.Its proprietary neuroblocking technology is designed to... 
More about the company
Latest news on ENTEROMEDICS INC
07/20 ENTEROMEDICS INC : Other Events (form 8-K)
07/20 ENTEROMEDICS : Assigned Patent
07/15 ENTEROMEDICS INC : Entry into a Material Definitive Agreement, Financial Stateme..
07/06 ENTEROMEDICS INC : Change in Directors or Principal Officers (form 8-K)
06/28 ENTEROMEDICS INC : Other Events (form 8-K)
06/08 ENTEROMEDICS : Assigned Patent
05/13 ENTEROMEDICS INC : Notice of Delisting or Failure to Satisfy a Continued Listing..
05/06 ENTEROMEDICS INC : Entry into a Material Definitive Agreement, Results of Operat..
05/05 ENTEROMEDICS : Reports First Quarter 2016 Financial Results
05/02 ENTEROMEDICS : Announces Exclusive Federal Government Business Channel Sales Agr..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
07/29DJSony Reports Surprise Profit
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
07/28DJTHERMO FISHER SCIENTIFIC : Beats Expectations, Raises Outlook
07/25DJADRs End Lower; Philips Rises
07/25DJPHILIPS : Cost Savings, Strong Sales Boost Philips' Earnings
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
01/05 Medtech Approvals Of The Strange Kind
2015 EnteroMedics Will Do 1 For 15 Reverse Split - This Is Not A Good Way To Start..
2015 ENTEROMEDICS TO REVERSE SPLIT SHARES : 15
2015 EnteroMedics' (ETRM) CEO Dan Gladney on Q3 2015 Results - Earnings Call Trans..
2015 EnteroMedics - Investors Need To Have Realistic Expectations
Advertisement
Chart ENTEROMEDICS INC
Duration : Period :
EnteroMedics Inc Technical Analysis Chart | ETRM | US29365M2089 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 3,75 $
Spread / Average Target 1 676%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Dan W. Gladney President, CEO & Class II Director
Mark B. Knudson Non-Executive Chairman
Peter M. Delange Senior VP-Operations & Business Development
Gregory S. Lea Secretary, Chief Financial & Compliance Officer
Scott A. Shikora Chief Medical Officer & VP-Medical Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ENTEROMEDICS INC53.73%2
THERMO FISHER SCIENTIF..11.98%62 505
BOSTON SCIENTIFIC CORP..31.67%32 945
INTUITIVE SURGICAL, IN..27.39%26 782
PHILIPS1.32%25 300
ILLUMINA, INC.-13.33%24 487
More Results